Neuroendocrine Tumor Overview

Save information for later
Sign Up

Learn About Neuroendocrine Tumor

What is the definition of Neuroendocrine Tumor?
Neuroendocrine tumors are rare cancers that grow from neuroendocrine cells. Neuroendocrine cells receive signals from the nervous system to release hormones. There are several types of neuroendocrine tumors, although most occur in the lungs, pancreas, adrenal glands, small intestine, appendix, and rectum. Neuroendocrine tumors may also spread to the lymph nodes, liver, or bones.
What are the symptoms of Neuroendocrine Tumor?
Symptoms of a neuroendocrine tumor depend on the tumor’s location and whether it is producing excess hormones. Symptoms of neuroendocrine tumors may include pain, a lump under the skin, fatigue, persistent cough or hoarseness, unexplained weight loss, confusion, anxiety, dizziness, shakiness, elevated blood glucose, low blood glucose, an ulcer, skin flushing, skin rash, increased thirst, nausea and vomiting, diarrhea, and carcinoid syndrome. Carcinoid syndrome is a condition that occurs when a neuroendocrine tumor produces excess hormones. Symptoms of carcinoid syndrome include skin flushing of the head and neck; sweating; shortness of breath; wheezing; rapid heartbeat; heart murmur; high blood pressure; yellowing of the skin and eyes; abdominal cramping; diarrhea; greasy, foul-smelling bowel movements; and swelling of the feet and legs.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Neuroendocrine Tumor?
Treatment for neuroendocrine tumors depends on the type and location, as well as whether the tumor is producing excess hormones. Treatment for endocrine tumors may include surgery; chemotherapy; targeted drug therapy, such as everolimus and sunitinib; immunotherapy, such as interferon alfa-2b; peptide receptor radionuclide therapy; somatostatin analogs, such as octreotide and lanreotide; radiation therapy; radiofrequency ablation; and hepatic artery embolization.
Who are the top Neuroendocrine Tumor Local Doctors?
Dr. Jaswinder P. Singh
Hematology Oncology | Hematology | Oncology
Dr. Jaswinder P. Singh
Hematology Oncology | Hematology | Oncology

Kansas City Urology Care PA

17525 Medical Ctr Pkwy, 
Independence, MO 
 (2.6 mi)
816-994-3150
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jaswinder Singh is a Hematologist Oncology specialist and a Hematologist in Independence, Missouri. Dr. Singh and is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, Bone Marrow Aspiration, and Endoscopy. Dr. Singh is currently accepting new patients.

Dr. Mohammad Mozayen
Hematology Oncology | Oncology | Hematology
Dr. Mohammad Mozayen
Hematology Oncology | Oncology | Hematology

Midwest Oncology Associates LLC

2316 E Meyer Blvd, Research Medical Center, 
Kansas City, MO 
 (9.5 mi)
816-276-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mohammad Mozayen is a Hematologist Oncology specialist and an Oncologist in Kansas City, Missouri. Dr. Mozayen and is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Lung Cancer, Childhood Iron Deficiency Anemia, and Familial Colorectal Cancer. Dr. Mozayen is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Louis A. Orlando
Internal Medicine
Dr. Louis A. Orlando
Internal Medicine

Centerpoint Physicians Group LLC

19550 E 39th St S, 335 Centerpoint Physicians, 
Independence, MO 
 (4.6 mi)
816-350-0005
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Louis Orlando is an Internal Medicine provider in Independence, Missouri. Dr. Orlando and is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Supravalvular Aortic Stenosis, Chronic Cough, Fainting, and Vertigo. Dr. Orlando is currently accepting new patients.

View All Doctors
What are the latest Neuroendocrine Tumor Clinical Trials?
A Phase II Multicenter Trial of ESK981 in Patients With Select Solid Tumors
A Phase II Multicenter Trial of ESK981 in Patients With Select Solid Tumors
Enrollment Status: Recruiting
Publish Date: February 26, 2025
Intervention Type: Drug
Study Phase: Phase 2

Summary: This protocol will enroll patients with pancreatic adenocarcinoma and adenosquamous carcinoma (Cohort 1), gastrointestinal/pancreatic neuroendocrine neoplasms with Ki-67 \> 20% (Cohort 2) and neuroendocrine prostate carcinoma (Cohort 3)). Each cohort will have its own interim analysis after enrollment of 10 patients. Subjects will be given a one-month (28 day) supply of study drug (ESK981). Subjec...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomised Study of Cessation of Somatostatin Analogues After Peptide Receptor Radionuclide Therapy in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours (STOPNET)
A Randomised Study of Cessation of Somatostatin Analogues After Peptide Receptor Radionuclide Therapy in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours (STOPNET)
Enrollment Status: Recruiting
Publish Date: February 26, 2025
Intervention Type: Drug
Study Phase: Phase 2

Summary: Neuroendocrine tumours (NETs) are slow growing cancers, which commonly present as metastatic incurable disease. Some neuroendocrine tumours, termed functional NETs, overproduce hormones which result in a variety of symptoms. However, approximately 75% of NETs are considered non-functional meaning that they do not result in hormone overproduction. The main treatment for both functional and non-func...

View All Clinical Trials
What are the Latest Advances for Neuroendocrine Tumor?
Paragangliomas - Essentials for the ENT Doctor
Paragangliomas - Essentials for the ENT Doctor
Journal: Laryngo- rhino- otologie
Published: February 03, 2025
Amelanotic Melanoma: Clinical Presentation, Diagnosis, and Management.
Amelanotic Melanoma: Clinical Presentation, Diagnosis, and Management.
Journal: Clinics in dermatology
Published: February 03, 2025
Tired of the same old research?
Check Latest Advances
A Recessive oca2 Mutation Underlies Albinism in Xiphophorus fish.
A Recessive oca2 Mutation Underlies Albinism in Xiphophorus fish.
Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025
View All Latest Advances